Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

This research addressed oral fingolimod (fty720) for relapsing multiple sclerosis. original article The new engl and jour nal of medicine n engl j med 355;11 www.nejm.org september 14, 2006 Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis Ludwig Kappos, M.D., Jack Antel,. Polman, M.D., Tomas Haas, Ph.D., Alexander A. These findings have important implications for understanding drugs in MS and improving patient outcomes. The results may inform clinical practice and guide development of more effective MS treatments. This work underscores the value of continued research in advancing MS care..